Roles of 21 Genera of Human Gut Microbiota in Barrett's Esophagus Risk: A Mendelian Randomization Study
Lack of definitive evidence supports the putative hypothesis that gut microbiota dysbiosis is associated with Barrett's esophagus (BE). We conducted a two-sample Mendelian randomization study to assess the associations of 21 genera of human gut microbiota with BE. We identified independent gene...
Gespeichert in:
Veröffentlicht in: | Frontiers in genetics 2022-06, Vol.13, p.894900 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Lack of definitive evidence supports the putative hypothesis that gut microbiota dysbiosis is associated with Barrett's esophagus (BE). We conducted a two-sample Mendelian randomization study to assess the associations of 21 genera of human gut microbiota with BE.
We identified independent genetic instruments for 21 genera of gut microbiota (including nine dominant genera, four core genera among individuals of European ancestry, and eight esophagus-specific genera of gut microbiota) from MiBioGen (up to 18,340 participants). We applied them to summary statistics from the largest publicly available genome-wide association study on BE (9,680 cases and 31,211 controls). We obtained the causal estimates of genetically predicted higher genera of gut microbiota and BE using the inverse variance weighting method. Sensitivity analyses included weighted median, MR-Egger, MR-RAPS, and MR-PRESSO.
We found that genetically predicted higher
(OR: 0.76 per unit increase in log odds of having BE, 95% CI: 0.70-0.83) and higher
(OR: 0.75, 95% CI: 0.63-0.90) were significantly associated with a lower risk of BE. No associations of other genera of gut microbiota with BE were noted, apart from suggestive associations of higher
(OR: 0.77; 95% CI: 0.61-0.99), higher
(OR: 0.89; 95% CI: 0.80-0.99), and higher
(OR: 0.76; 95% CI: 0.56-1.02) with a lower risk of BE, and higher
(OR: 1.15; 95% CI: 0.99-1.33) with a higher risk of BE.
This study suggests that higher
and higher
might protect against BE. |
---|---|
ISSN: | 1664-8021 1664-8021 |
DOI: | 10.3389/fgene.2022.894900 |